Tag: John Whelan
John Whelan: Trump’s Generic Drug Tariff Plan Raises Irish Concerns
John Whelan highlights the potential implications of Trump's tariff plan on generic drugs, raising concerns among Irish stakeholders.
John Whelan: Trump’s Generic Drug Tariff Plan Raises Irish Concerns
John Whelan discusses the implications of Trump's tariffs on generic drugs and their potential impact on Ireland's pharmaceutical industry.
John Whelan: Trump’s Generic Drug Tariff Plan Raises Irish Concerns
Irish concerns are mounting over Trump's proposed tariff plan on generic drugs, as experts warn of potential negative impacts on healthcare costs and access.
John Whelan: Trump’s Generic Drug Tariff Plan Raises Concerns in Ireland
As President Trump’s proposed tariff on generic drugs moves forward, Irish stakeholders express deep concerns about its implications for health care and the pharmaceutical industry in Ireland.
